Method for co-production of N-substituted caprolactam

Through the two-step method of doping the whole silicon MFI molecular sieve catalyst with modified elements, the yield and selectivity of N-methylcaprolactam are improved, and the problems of limited yield and poor economic performance in the prior art are solved, thus achieving high efficiency and low efficiency Cost N-substituted caprolactam production.

CN119059952AActive Publication Date: 2024-12-03CHINA PETROLEUM & CHEMICAL CORP +1
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202310630406.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-31
Publication Date
2024-12-03
Estimated Expiration
2043-05-31

AI Technical Summary

Technical Problem

In the prior art, the yield of N-methylcaprolactam is limited and economically poor. The content of high value-added products in the gas-phase Beckman rearrangement reaction is low, and the catalyst is prone to deactivate and difficult to be used in industrial use.

Method used

Using a two-step method of doping all-silicon MFI molecular sieve catalyst with modified elements, gas-phase rearrangement reaction is performed first, and then N-alkylation reaction is carried out to improve the acidic center and reaction activity of the catalyst, and enhance the yield of N-substituted caprolactam. and selective.

Benefits of technology

The content of high added value N-substituted caprolactam and the total selectivity of caprolactam and N-substituted caprolactam are increased, the production cost is reduced, the catalyst life is extended, the process route is simplified, and it is suitable for industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004258193060000131
    Figure BDA0004258193060000131
  • Figure BDA0004258193060000141
    Figure BDA0004258193060000141
  • Figure BDA0004258193060000142
    Figure BDA0004258193060000142
Patent Text Reader

Abstract

The present invention relates to the technical field of caprolactam derivative preparation, and discloses a method for co-production of N-substituted caprolactam, the method comprises: contacting a first cyclohexanone-oxime material flow with a first catalyst to carry out a gas phase rearrangement reaction, and then contacting a material flow containing a product of the gas phase rearrangement reaction with a second catalyst to carry out an N-alkylation reaction, the first cyclohexanone-oxime material flow contains cyclohexanone-oxime and an alcohol solvent; wherein the first catalyst is an all-silicon type MFI molecular sieve catalyst; the second catalyst comprises an MFI molecular sieve and a modification element, the MFI molecular sieve contains a doping element, the doping element has a + 3-valence ion valence state and / or a + 4-valence ion valence state, and the modification element comprises phosphorus and a rare earth element. According to the method, the content of high-added-value N-substituted (methyl or ethyl) caprolactam in the product can be effectively improved, and the total selectivity of caprolactam and N-substituted caprolactam is improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of preparation of caprolactam derivatives, and in particular to a method for co-producing N-substituted caprolactam. Background Art

[0002] N-substituted caprolactam, including N-methyl caprolactam and N-ethyl caprolactam, is a class of organic chemicals with high added value. Among them, N-methyl caprolactam is a new type of solvent, which is widely used in the separation and organic synthesis of organic matter. It can also be used as a diluent, extractant, cleaning agent, degreasing agent, absorbent and dispersant; N-ethyl caprolactam is an important organic synthesis intermediate and solvent.

[0003] The traditional synthesis method of N-methylcaprolactam is to use caprolactam as raw material, methyl iodide or dimethyl sulfate as methylating agent, and add phase transfer catalyst to synthesize under strong base NaOH or KOH, K2CO3 mixed base conditions. However, this method has harsh reaction conditions and high cost.

[0004] CN103547569A discloses a method for manufacturing N-substituted lactam compounds, which is prepared by reacting lactone and organic amine as raw materials, and the product separation process is complicated. CN107056567A discloses a novel method for synthesizing N-substituted amide derivatives, which uses SO / MO solid superacid catalyst, caprolactone and ammonia (amine) as raw materials in a fixed bed, reacts at 180.0-320.0°C, and the product is collected by condensation, dehydrated, and desolvated to obtain high-purity caprolactam and N-substituted caprolactam, with a yield of more than 95%. However, due to the use of solid superacid as a catalyst, water and alkaline ammonia (amine) are present under the reaction conditions, and the catalyst is easily deactivated, making it difficult to apply in industrial production.

[0005] US20210179562A1 discloses a method for synthesizing N-alkylated lactam by reduction method, in which formaldehyde is added to caprolactam in the presence of a catalyst with a precious metal content of 10% and under H2 reducing atmosphere, and the reaction is carried out at 100°C for 18 hours, and the yield of N-methyl caprolactam is 71%. Since hydrogen and precious metal catalysts are used in the reaction process, the production cost is high, and caprolactam may also undergo hydrogenation reaction, which reduces the yield of the target product.

[0006] In addition, N-substituted caprolactam is also a by-product of the gas phase Beckmann rearrangement reaction of cyclohexanone oxime. In order to recycle some high value-added impurities, CN109574929A discloses a method for separating and purifying N-methyl caprolactam from the light impurity components of the gas phase Beckmann rearrangement product of cyclohexanone oxime. The method is used to separate the impurities of the gas phase Beckmann rearrangement product of cyclohexanone oxime, and separate and purify to obtain N-methyl caprolactam. However, due to the high temperature of the gas phase Beckmann rearrangement reaction, it often contains a variety of impurities, and the content of high value-added N-methyl caprolactam is low. In addition, the catalyst is a weakly acidic all-silicon molecular sieve, which has insufficient acidic centers, and the output of N-methyl caprolactam is limited, and the economy is poor. Summary of the invention

[0007] The purpose of the present invention is to overcome the problems of limited N-methyl caprolactam production and poor economy in the prior art, and to provide a method for co-producing N-substituted caprolactam. The method can improve the total selectivity of caprolactam and N-substituted caprolactam in a gas-phase Beckmann rearrangement reaction, efficiently co-produce N-substituted caprolactam, have a simple process route, low cost, and be conducive to industrial application.

[0008] In order to achieve the above object, the present invention provides a method for co-producing N-substituted caprolactam, which comprises: contacting a first cyclohexanone oxime stream with a first catalyst to perform a gas phase rearrangement reaction, and then contacting a stream containing a product of the gas phase rearrangement reaction with a second catalyst to perform an N-alkylation reaction; the first cyclohexanone oxime stream contains cyclohexanone oxime and an alcohol solvent;

[0009] Among them, the first catalyst is an all-silicon MFI molecular sieve catalyst; the second catalyst includes an MFI molecular sieve and a modifying element, the MFI molecular sieve contains a doping element, the doping element has an ionic valence state of +3 and / or an ionic valence state of +4, and the modifying element includes phosphorus and rare earth elements.

[0010] Due to the high reaction temperature of the vapor-phase Beckmann rearrangement reaction, it often contains a variety of impurities and has a low content of high-value-added N-methyl caprolactam. At the same time, since the catalysts used in the existing vapor-phase Beckmann rearrangement reaction are generally weakly acidic all-silicon molecular sieves, the acid centers are insufficient, which also limits the production of N-methyl caprolactam and leads to poor economic efficiency of co-production.

[0011] The method for co-producing N-substituted caprolactam provided by the present invention can increase the content of high value-added N-substituted (methyl or ethyl) caprolactam in the product, increase the total selectivity of caprolactam and N-substituted caprolactam, improve the technical and economical efficiency, and the catalyst life is not affected and the catalyst regeneration cycle does not change. The method has the advantages of simple process route, easy industrial production, and green environmental protection. DETAILED DESCRIPTION

[0012] The endpoints and any values ​​of the ranges disclosed in this article are not limited to the precise ranges or values, and these ranges or values ​​should be understood to include values ​​close to these ranges or values. For numerical ranges, the endpoint values ​​of each range, the endpoint values ​​of each range and the individual point values, and the individual point values ​​can be combined with each other to obtain one or more new numerical ranges, which should be considered as specifically disclosed in this article.

[0013] The present invention provides a method for co-producing N-substituted caprolactam, which comprises: contacting a first cyclohexanone oxime stream with a first catalyst to perform a gas phase rearrangement reaction, and then contacting a stream containing a product of the gas phase rearrangement reaction with a second catalyst to perform an N-alkylation reaction; the first cyclohexanone oxime stream contains cyclohexanone oxime and an alcohol solvent;

[0014] Among them, the first catalyst is an all-silicon MFI molecular sieve catalyst; the second catalyst includes an MFI molecular sieve and a modifying element, the MFI molecular sieve contains a doping element, the doping element has an ionic valence state of +3 and / or an ionic valence state of +4, and the modifying element includes phosphorus and rare earth elements.

[0015] In the present invention, the cyclohexanone oxime gas phase Beckmann rearrangement reaction process and the N-alkylation process are both present in the gas phase rearrangement reaction and the N-alkylation reaction, and the alcohol solvent simultaneously plays the role of gas phase Beckmann rearrangement reaction solvent and alkylation agent. Since the gas phase Beckmann rearrangement reaction temperature is high, it often contains a variety of impurities, and the content of high value-added N-methyl caprolactam is low. At the same time, since the catalyst used in the existing gas phase Beckmann rearrangement reaction is generally a weakly acidic all-silicon molecular sieve, the acid center is insufficient, which also limits the output of N-methyl caprolactam, resulting in poor co-production economic efficiency. In the present invention, through the combination of the first catalyst and the second catalyst, a high concentration of N-substituted (methyl or ethyl) caprolactam is co-produced in the process of generating caprolactam, which can effectively increase the content of high value-added N-substituted (methyl or ethyl) caprolactam in the product, improve the total selectivity of caprolactam and N-substituted caprolactam, and improve technical and economic efficiency.

[0016] In the present invention, the first catalyst and the second catalyst can be loaded in two reactors connected in series, or loaded in two independent reaction zones of the same reactor. The present invention has no particular limitation on this, as long as the first cyclohexanone oxime flow can be first contacted with the first catalyst, and then the obtained flow containing the product of the gas-phase rearrangement reaction can be contacted with the second catalyst.

[0017] According to a preferred embodiment of the present invention, the logistics comprising the product of the gas phase rearrangement reaction also includes a second cyclohexanone oxime logistics. The composition of the second cyclohexanone oxime logistics may be the same as or different from the composition of the first cyclohexanone oxime logistics. The above preferred embodiment is conducive to further improving the selectivity of N-substituted caprolactam.

[0018] Preferably, the mass ratio of the second cyclohexanone oxime stream to the first cyclohexanone oxime stream is 0.1-1:1, for example, it can be 0.1:1, 0.2:1, 0.3:1, 0.4:1, 0.5:1, 0.6:1, 0.7:1, 0.8:1, 0.9:1, 1:1 and other typical but non-limiting ratios or ranges therebetween.

[0019] According to the present invention, preferably, the mass ratio of the second catalyst to the first catalyst is 0.1-1: 1. For example, it can be 0.1: 1, 0.2: 1, 0.3: 1, 0.4: 1, 0.5: 1, 0.6: 1, 0.7: 1, 0.8: 1, 0.9: 1, 1: 1, etc., which are typical but non-limiting ratios or ranges therebetween.

[0020] According to the present invention, the first catalyst is an all-silicon MFI molecular sieve catalyst, preferably a silicalite-1 molecular sieve, which does not contain aluminum atoms and does not cause dealumination under high temperature conditions. The all-silicon MFI molecular sieve catalyst can be purchased from a commercial source or prepared using any known preparation method in the art.

[0021] In the conventional MFI molecular sieve catalyst used in the gas-phase Beckmann rearrangement reaction of cyclohexanone oxime, in order to ensure the high selectivity of the caprolactam product, its metal content is very low, its acid center is a weak acid silanol nest, there is no other acid center, the number of acid centers is insufficient, and the output of N-substituted (methyl or ethyl) caprolactam is limited. In the present invention, the second catalyst contains MFI molecular sieve and modifying elements, and at the same time, the doping elements with +3 valence ion state and / or +4 valence ion state are introduced into the MFI molecular sieve framework to modify the catalyst, which is beneficial to increase the number of N-substituted (methyl or ethyl) caprolactam reaction active centers. The second catalyst is combined with the all-silicon MFI molecular sieve catalyst to strengthen the reaction characteristics of the two and increase the content of N-substituted caprolactam in the product.

[0022] In the conventional MFI molecular sieve catalyst of the prior art, the metal content is very low to ensure high selectivity of the caprolactam product. In the present invention, the content of the doping element is relatively high. Preferably, based on the total amount of the MFI molecular sieve, the content of the doping element is 0.01-3wt%.

[0023] In a further preferred embodiment, the doping element having an ionic valence state of +3 is selected from at least one of B, Al and Fe, preferably Al.

[0024] Preferably, based on the total amount of the MFI molecular sieve, the content of the doping element with an ionic valence of +3 is 0.01-0.2wt%, for example, it can be 0.01wt%, 0.02wt%, 0.03wt%, 0.04wt%, 0.05wt%, 0.06wt%, 0.07wt%, 0.08wt%, 0.09wt%, 0.1wt%, 0.15wt%, 0.2wt% or the like typical but non-limiting content or the range therebetween, more preferably 0.02-0.1wt%.

[0025] In another preferred embodiment, the doping element having an ionic valence state of +4 is selected from at least one of Ti, Zr and Sn, preferably Ti.

[0026] Preferably, based on the total amount of the MFI molecular sieve, the content of the doping element with an ionic valence of +4 is 0.1-3wt%, for example, it can be 0.1wt%, 0.2wt%, 0.3wt%, 0.4wt%, 0.5wt%, 0.6wt%, 0.7wt%, 0.8wt%, 0.9wt%, 1wt%, 1.2wt%, 1.5wt%, 1.8wt%, 2wt%, 2.2wt%, 2.5wt%, 2.8wt%, 3wt% and other typical but non-limiting contents or a range therebetween, preferably 2-3wt%.

[0027] According to the present invention, preferably, in the modified elements, the mass ratio of rare earth elements to phosphorus is 1-10:1, calculated as elements, for example, it can be 1:1, 1.5:1, 2:1, 2.5:1, 3:1, 3.5:1, 4:1, 5:1, 6:1, 7:1, 8:1, 9:1, 10:1 and other typical but non-limiting ratios or ranges therebetween. Preferably, in terms of elements, the mass ratio of rare earth elements to phosphorus is 1-3:1. In the above preferred case, the synergistic effect of phosphorus and rare earth elements can be further exerted, which helps to increase the content of N-substituted caprolactam in the product.

[0028] In the present invention, the rare earth element refers to a lanthanide element. Preferably, the rare earth element is selected from La and / or Ce.

[0029] Preferably, in the second catalyst, the content of the rare earth element is 0.01-0.2wt%, preferably 0.05-0.1wt%; the content of the phosphorus element is 0.01-0.1wt%, preferably 0.01-0.04wt%.

[0030] In the present invention, the content of trace elements in the catalyst is measured by the ICP method.

[0031] According to a specific embodiment of the present invention, the preparation method of the second catalyst comprises:

[0032] (1) mixing a silicon source, a doping element precursor, an organic template, water and an alcohol to obtain a mixture; wherein the silicon source is an organic silicate, and the molar ratio of the silicon source, the organic template, the alcohol and the water in the mixture calculated as SiO2 is 1:(0.05-0.5):(4-10):(5-100);

[0033] (2) subjecting the mixture to hydrothermal crystallization, followed by drying and calcining to obtain an MFI molecular sieve;

[0034] (3) impregnating the MFI molecular sieve with a solution containing a phosphorus source and a rare earth element precursor;

[0035] (4) contacting the product obtained in step (3) with an alkaline buffer solution of a nitrogen-containing compound.

[0036] In a further preferred embodiment, in the mixture, the molar ratio of the silicon source, the organic template, the alcohol and the water calculated as SiO2 is 1:(0.2-0.3):(6-8):(10-20).

[0037] Preferably, the silicon source is tetraethyl orthosilicate.

[0038] The organic template can be various organic templates conventionally used in the art for preparing all-silicon-1 molecular sieves. Preferably, the organic template is selected from quaternary ammonium base compounds, and the quaternary ammonium base compounds can be alkyl quaternary ammonium base compounds containing 1-4 carbon atoms, further preferably tetrapropylammonium hydroxide and / or tetraethylammonium hydroxide, and more preferably tetrapropylammonium hydroxide.

[0039] The present invention has a wide selection range for the specific type of the doping element precursor, which can be selected from soluble compounds containing the doping element. Those skilled in the art can make the selection according to actual needs.

[0040] In a specific embodiment, the doping element is Al, and preferably, the precursor of Al is pseudo-boehmite.

[0041] In some specific embodiments of the present invention, step (1) comprises: firstly mixing pseudo-boehmite with a part of the organic template and hydrolyzing it, and then mixing the hydrolysis product with a silicon source, the remaining part of the organic template, water and alcohol. The present invention does not specifically limit the specific operation and conditions of the hydrolysis, and those skilled in the art can select according to actual needs. Preferably, the hydrolysis temperature is 120-160°C and the time is 2-5h.

[0042] According to the present invention, the amount of the doping element precursor calculated as the doping element is such that the doping element content in the prepared second catalyst satisfies the range defined above, which will not be repeated here. Preferably, the mass ratio of the amount of the doping element precursor calculated as the doping element to the silicon source calculated as SiO2 is 0.0001-0.03:1.

[0043] Preferably, the conditions for the hydrothermal crystallization include: a temperature of 80-200° C., preferably 95-170° C.; and a time of 0.5-10 days, preferably 2-5 days.

[0044] Preferably, in step (2), the drying conditions include: temperature of 100-150° C. and time of 10-24 h.

[0045] Preferably, in step (2), the calcination conditions include: temperature of 450-600° C. and time of 1-10 h.

[0046] Preferably, the step (2) further comprises: optionally washing and solid-liquid separation of the product obtained by the hydrothermal crystallization, and then drying and calcining. The present invention has no particular limitation on the specific operation mode and conditions of the washing and solid-liquid separation, and the washing and solid-liquid separation can be carried out in a conventional manner in the art.

[0047] According to the present invention, step (3) uses an impregnation method to load phosphorus and rare earth elements on the MFI molecular sieve. The present invention has no particular limitation on the amount of the solution containing the phosphorus source and the rare earth element precursor, as long as the above-mentioned loading process can be achieved, for example, a saturated impregnation method can be used.

[0048] According to the present invention, the specific types of the phosphorus source and the rare earth element precursor are not particularly limited, as long as they can provide phosphorus and rare earth elements, and conventional soluble compounds containing phosphorus / rare earth elements in the art can be used. The phosphorus source is preferably a phosphate, such as ammonium phosphate. The rare earth element precursor can be at least one of a nitrate, a sulfate and a chloride of a rare earth element.

[0049] The contents of the phosphorus source and the rare earth element precursor in the solution containing the phosphorus source and the rare earth element precursor are based on the content of the phosphorus element and the rare earth element in the second catalyst defined above, and can be adjusted according to actual needs, which will not be elaborated here.

[0050] Preferably, the impregnation conditions include: a temperature of 80-100° C., preferably 80-90° C., and a time of 5-10 h, preferably 6-8 h.

[0051] Preferably, the step (3) further comprises: drying and calcining the impregnated product. The drying temperature is 100-130° C. The present invention has no particular limitation on the drying time, as long as the residual solvent can be removed.

[0052] Preferably, the calcination temperature is 400-500° C. and the calcination time is 4-6 hours.

[0053] In the present invention, the product obtained in step (3) is contacted with an alkaline buffer solution of a nitrogen-containing compound. Preferably, the mass ratio of the product obtained in step (3) to the alkaline buffer solution of a nitrogen-containing compound is 1:5-20, preferably 1:5-10.

[0054] Preferably, the alkaline buffer solution of the nitrogen-containing compound contains an ammonium salt and a base, and the solvent in the alkaline buffer solution of the nitrogen-containing compound may be water.

[0055] Preferably, the ammonium salt is provided by an aqueous solution of ammonium salt, and the concentration of the aqueous solution of ammonium salt is 5-10 wt%.

[0056] Preferably, the ammonium salt is selected from at least one of ammonium nitrate, ammonium chloride and ammonium acetate.

[0057] Preferably, the alkali is provided by aqueous ammonia, and the concentration of aqueous ammonia is 10-30 wt%.

[0058] Preferably, in the alkaline buffer solution of the nitrogen-containing compound, the mass ratio of ammonia water to the aqueous solution of ammonium salt is 1-5:1, preferably 2-3:1.

[0059] Preferably, the contacting conditions are: temperature of 70-100° C., pressure of 0.2-0.3 MPa, and contact time of 0.5-2 h. Preferably, the contacting is performed under stirring conditions.

[0060] Preferably, the preparation method further comprises: solid-liquid separation, washing and drying of the contacted product. The solid-liquid separation, washing and drying can be carried out in a conventional manner in the art, and the present invention has no particular limitation thereto.

[0061] According to the present invention, preferably, the conditions of the gas phase rearrangement reaction include: a reaction temperature of 300-500°C, preferably 350-400°C, a reaction pressure of 0.1-0.5MPa, preferably 0.1-0.3MPa, and a weight space velocity of the reaction raw materials calculated as cyclohexanone oxime of 0.1-16h -1 , preferably 1-8h -1 .

[0062] Preferably, the conditions of the N-alkylation reaction include: a reaction temperature of 300-500° C., preferably 300-380° C., and a reaction pressure of 0.1-0.5 MPa, preferably 0.1-0.3 MPa.

[0063] In the present invention, the conditions of the gas-phase rearrangement reaction and the conditions of the N-alkylation reaction may be the same or different. In order to further increase the content of high value-added N-substituted (methyl or ethyl) caprolactam in the product and improve the overall selectivity of caprolactam and N-substituted caprolactam, preferably, the temperature of the N-alkylation reaction is 20-100°C lower than the temperature of the gas-phase rearrangement reaction. Preferably, the temperature of the N-alkylation reaction is 30-50°C lower than the temperature of the gas-phase rearrangement reaction.

[0064] According to a specific embodiment of the present invention, the gas phase rearrangement reaction and N-alkylation reaction are carried out under an inert atmosphere, and the inert atmosphere is provided by an inert gas.

[0065] Preferably, the inert gas is selected from at least one of nitrogen, helium, argon and neon, preferably nitrogen.

[0066] Preferably, the molar ratio of the inert gas to the first cyclohexanone oxime stream is 10-80:1, preferably 20-50:1.

[0067] Preferably, the alcohol solvent is methanol and / or ethanol. Preferably, in the first cyclohexanone oxime stream, the mass ratio of cyclohexanone oxime to alcohol is 1:1-5, preferably 1:2-3.

[0068] In a further preferred embodiment, the method further comprises: separating the product obtained from the N-alkylation reaction to obtain an N-substituted caprolactam product.

[0069] The separation can be carried out by the method for separating and purifying N-methyl caprolactam from the light impurity components of the gas-phase Beckmann rearrangement product of cyclohexanone oxime disclosed in CN109574929A. The separation can also include steps such as dehydration, desolvation, extraction and concentration, and can be carried out by any method known in the art, and the present invention has no particular limitation on this.

[0070] The present invention will be described in detail below through examples.

[0071] In the following preparation examples and embodiments, unless otherwise specified, the raw materials used were commercially available.

[0072] The following preparation example is used to illustrate the preparation of the first catalyst.

[0073] Preparation Example 1-1

[0074] (1) At room temperature, 440 g of tetraethyl orthosilicate (TEOS), 600 g of deionized water, ethanol, and 440 g of 24.5 wt% tetrapropylammonium hydroxide (TPAOH) were poured into a beaker and mixed and stirred for 30 min to obtain a mixture with a molar content of TPAOH / SiO2=0.25, EtOH / SiO2=6, and H2O / SiO2=16.

[0075] (2) The mixture was transferred into a stainless steel reactor and crystallized at 115°C for 3 days, filtered and washed, and calcined at 550°C for 4 hours to obtain an all-silicon MFI molecular sieve. XRD characterization showed that the XRD spectrum characteristics were consistent with those of the MFI structure standard, indicating that the molecular sieve had an MFI crystal structure.

[0076] (3) 10 g of the product obtained in step (2) and 100 g of the above-mentioned alkaline buffer solution (the concentration of ammonia water is 26% by weight, the concentration of ammonium nitrate aqueous solution is 7.5% by weight, and the weight ratio of ammonia water to ammonium nitrate aqueous solution is 2:1) are added to a pressurized reactor, stirred at 80°C and 0.23 MPa for 1 hour, and then filtered, washed, and dried to obtain catalyst A1.

[0077] The following preparation example is used to illustrate the preparation of the second catalyst.

[0078] Preparation Example 2-1

[0079] (1) 0.2 g of pseudo-boehmite was mixed with 240 g of 24.5 wt% tetrapropylammonium hydroxide and hydrolyzed in a pressure vessel at 140° C. for 3 h.

[0080] (2) At room temperature, 440 g of tetraethyl orthosilicate (TEOS), 600 g of deionized water, ethanol, and 200 g of 24.5 wt% tetrapropylammonium hydroxide (TPAOH) were poured into a beaker and mixed and stirred for 30 min. Then, the solution in step (1) was added and stirred evenly to obtain a mixture with a molar content of TPAOH / SiO2=0.25, EtOH / SiO2=6, and H2O / SiO2=16, wherein the mass ratio of Al / SiO2 was 0.0006:1.

[0081] (3) The mixture was transferred into a stainless steel reactor and crystallized at 115° C. for 3 days, filtered and washed, and calcined at 550° C. for 4 hours to obtain an MFI molecular sieve. Based on the total amount of the MFI molecular sieve, the Al content was 0.06 wt%.

[0082] (4) 0.46 g of lanthanum nitrate and 0.48 g of ammonium phosphate were dissolved in 100 g of deionized water, 250 g of molecular sieve raw powder was pre-vacuumed at room temperature for 0.5 h, the solution was absorbed, the mixture was immersed at 85° C. for 6 h, the water was evaporated and dried at 120° C., and then calcined at 450° C. for 4 h.

[0083] (5) Add 10 g of the product obtained in step (4) and 100 g of alkaline buffer solution (the concentration of ammonia water is 26% by weight, the concentration of ammonium nitrate aqueous solution is 7.5% by weight, and the weight ratio of ammonia water to ammonium nitrate aqueous solution is 2:1) into a pressure reactor, stir at 80°C and 0.23 MPa for 1 hour, then filter, wash and dry to obtain catalyst S1. The amount of lanthanum element is 0.08wt%, and the mass ratio of lanthanum to phosphorus is 2:1. The catalyst is labeled S1.

[0084] Preparation Example 2-2

[0085] (1) At room temperature, 440 g of tetraethyl orthosilicate (TEOS), 600 g of deionized water, ethanol, and 440 g of 24.5 wt% tetrapropylammonium hydroxide (TPAOH) were poured into a beaker, mixed and stirred for 30 minutes, and then 17 g of tetrabutyl titanate was added and stirred evenly to obtain a mixture with a molar content of TPAOH / SiO2=0.25, EtOH / SiO2=6, and H2O / SiO2=16, wherein the mass ratio of Ti / SiO2 was 0.02:1.

[0086] (2) The mixture was transferred into a stainless steel reactor for crystallization at 170° C. for 3 days, filtered and washed, and calcined at 560° C. for 5 hours to obtain an MFI molecular sieve, wherein the content of Ti was 2% based on the total amount of the MFI molecular sieve.

[0087] (3) 0.46 g of lanthanum nitrate and 0.49 g of ammonium phosphate were dissolved in 100 g of deionized water, 250 g of molecular sieve raw powder was pre-vacuumed at room temperature for 0.5 h, the solution was absorbed, the mixture was immersed at 85° C. for 6 h, the water was evaporated and dried at 120° C., and then calcined at 450° C. for 3 h.

[0088] (4) Add 10 g of the product obtained in step (3) and 100 g of alkaline buffer solution (ammonia content of 26% by weight, ammonium nitrate content of 7.5% by weight, and weight ratio of ammonia water to ammonium nitrate aqueous solution of 2:1) into a pressure reactor, stir at 80°C and 0.23 MPa for 1 hour, then filter, wash and dry to obtain a catalyst. The amount of lanthanum element is 0.08 wt%, and the mass ratio of lanthanum to phosphorus is 2:1. The catalyst is labeled S2.

[0089] Preparation Example 2-3

[0090] The method of Preparation Example 2-1 is followed, except that the amount of pseudo-boehmite used in the solution in step (1) is 0.02 g.

[0091] In the prepared MFI molecular sieve, the content of Al is 0.006 wt % based on the total amount of the MFI molecular sieve.

[0092] Steps (4) and (5) were carried out in the same manner, and the obtained catalyst was denoted as S3.

[0093] Preparation Example 2-4

[0094] According to the method of Preparation Example 2-2, the difference is that the amount of lanthanum nitrate used is 0.46g, the amount of ammonium phosphate used is 2g, and the prepared catalyst is recorded as S4, wherein the contents of lanthanum and phosphorus are 0.08wt% and 0.16% respectively, and the mass ratio of lanthanum to phosphorus is 1:2. The catalyst is labeled as S4.

[0095] Comparative Preparation Example 1

[0096] The method of Preparation Example 2-1 was followed, except that step (4) was not performed, and the MFI molecular sieve obtained in step (3) was directly contacted with the alkaline buffer solution. The obtained catalyst was recorded as DS1.

[0097] Comparative Preparation Example 2

[0098] The method of Preparation Example 2-2 was followed, except that step (4) was not performed, and the MFI molecular sieve obtained in step (3) was directly contacted with the alkaline buffer solution. The obtained catalyst was recorded as DS2.

[0099] The following examples are used to illustrate the method for co-producing N-substituted caprolactam

[0100] Two fixed-bed reactors connected in series were used for the gas-phase Beckmann rearrangement reaction of cyclohexanone oxime, the first being a rearrangement reactor and the second being an N-alkylation reactor. The inner diameter of each reactor was 5 mm, and the catalyst was loaded according to the combination shown in Tables 1 and 2. 60-mesh 30-mm-high quartz sand was loaded on the catalyst bed, and 60-mesh 60-mm-high quartz sand was loaded below the catalyst bed.

[0101] In the presence of nitrogen (flow rate of 1500mL / min), the first cyclohexanone oxime stream (the mass ratio of cyclohexanone oxime to alcohol is 1:2) is introduced into the reaction system through the feed port of the rearrangement reactor for reaction, and then the product of the gas phase rearrangement reaction and the second cyclohexanone oxime stream (the mass ratio of cyclohexanone oxime to alcohol is 1:2) are introduced into the N-alkylation reactor through the feed port of the N-alkylation reactor. The embodiment of using methanol as the reaction solvent is shown in Table 1, and the embodiment of using ethanol as the reaction solvent is shown in Table 2. The reaction product is cooled by an ice-water mixture and enters a collection bottle for gas-liquid separation, and the product composition analysis is performed after 24 hours of reaction.

[0102] Table 3 shows the changes in the selectivity of N-alkyl caprolactam during the reaction process in Example 1 and Comparative Example 1 and Comparative Example 2.

[0103] The reaction products were quantitatively analyzed using an Agilent 6890 gas chromatograph (hydrogen flame ionization detector, PEG20M capillary column, column length 50 m). The contents of cyclohexanone oxime, caprolactam and N-substituted (methyl or ethyl) caprolactam after the reaction were calculated using the area normalization method, and the solvent was not involved in the integration.

[0104] The cyclohexanone oxime conversion rate and the caprolactam and N-substituted (methyl or ethyl) caprolactam selectivities were calculated according to the following formula.

[0105] Cyclohexanone oxime conversion rate (mol%) = (100-cyclohexanone oxime molar percentage in the reaction product) / 100×100%;

[0106] Caprolactam selectivity (or N-substituted (methyl or ethyl) caprolactam) (mol%) = mole percentage of caprolactam (or N-substituted (methyl or ethyl) caprolactam) in the reaction product / (100-mole percentage of cyclohexanone oxime in the reaction product)×100%.

[0107] Table 1 Reaction results using methanol as solvent

[0108]

[0109]

[0110] *Total selectivity refers to the total selectivity of caprolactam + N-methylcaprolactam.

[0111] Table 2 Reaction results using ethanol as solvent

[0112]

[0113]

[0114] According to the method of separating the reaction product in Example 1 of CN109574929A, the purity of N-methyl caprolactam in the aqueous phase after extraction is 97.9wt%, and the aqueous solution is evaporated under reduced pressure to remove water (evaporation conditions: temperature 75°C, pressure 10kPa), and finally a N-methyl caprolactam product with a purity of 98.4wt% is obtained. After the N-methyl caprolactam content in the reaction product is increased, its purity is correspondingly improved through subsequent separation procedures. According to the above method, the reaction products in Example 6 and Comparative Example 5 are separated, and the purity of N-ethyl caprolactam obtained is 98.6 and 97.0wt% respectively. It can be seen that after the N-ethyl caprolactam content in the reaction product is increased, it is further beneficial to improve the purity of the N-ethyl caprolactam obtained by separation.

[0115] As can be seen from the results in Table 1, the method provided by the present invention improves the conversion rate of cyclohexanone oxime, and can significantly increase the content of high value-added N-methyl caprolactam from 0.4% to about 2-2.2%, and the total selectivity of N-methyl caprolactam + caprolactam is slightly improved, so that the yield of cyclohexanone oxime converted into valuable target products is increased, but the economic efficiency of the product is improved. As can be seen from the results in Table 2, the content of N-ethyl caprolactam is increased, which is conducive to improving the economic efficiency of the product.

[0116] Table 3 Selectivity of N-methylcaprolactam at different reaction times, mol%

[0117]

[0118]

[0119] The change of N-methyl caprolactam content under different reaction times of 0-24h was investigated by the reaction methods in Example 1, Comparative Examples 1 and 2. From the data in Table 3, it can be seen that the N-methyl caprolactam content of the method provided in Example 1 increased to 1.5mol% after 2h of reaction, and then the selectivity was basically stable at 2mol%; however, in Comparative Examples 1 and 2, the catalyst N-alkylation reaction selectivity was the highest at the initial stage of the reaction, and the N-methyl caprolactam selectivity could reach 1.14mol%. During the reaction, as the reaction time was prolonged, the byproduct N-methyl CPL content gradually decreased, and after 24h of reaction, its selectivity gradually decreased to 0.4-0.55mol%. It can be seen that the N-methyl caprolactam content was unstable during the reaction, and the low content resulted in high separation cost and poor technical and economic performance.

[0120] The preferred embodiments of the present invention are described in detail above, but the present invention is not limited thereto. Within the technical concept of the present invention, the technical solution of the present invention can be subjected to a variety of simple modifications, including the combination of various technical features in any other suitable manner, and these simple modifications and combinations should also be regarded as the contents disclosed by the present invention and belong to the protection scope of the present invention.

Claims

1. A method for co-producing N-substituted caprolactam, the method comprising: contacting a first cyclohexanone oxime stream with a first catalyst to perform a gas phase rearrangement reaction, and then contacting a stream containing a product of the gas phase rearrangement reaction with a second catalyst to perform an N-alkylation reaction; wherein the first cyclohexanone oxime stream contains cyclohexanone oxime and an alcohol solvent; Among them, the first catalyst is an all-silicon MFI molecular sieve catalyst; the second catalyst includes an MFI molecular sieve and a modifying element, the MFI molecular sieve contains a doping element, the doping element has an ionic valence state of +3 and / or an ionic valence state of +4, and the modifying element includes phosphorus and rare earth elements.

2. The method according to claim 1, wherein: The stream comprising the product of the gas phase rearrangement reaction also includes a second cyclohexanone oxime stream; Preferably, the mass ratio of the second cyclohexanone oxime stream to the first cyclohexanone oxime stream is 0.1-1:

1.

3. The method according to claim 1 or 2, wherein: The mass ratio of the second catalyst to the first catalyst is 0.1-1:

1.

4. The method according to any one of claims 1 to 3, wherein: The MFI molecular sieve is a silicalite-1 type molecular sieve; And / or, based on the total amount of the MFI molecular sieve, the content of the doping element is 0.01-3wt%.

5. The method according to any one of claims 1 to 4, wherein: The doping element having an ionic valence state of +3 is selected from at least one of B, Al and Fe, preferably Al; Preferably, based on the total amount of the MFI molecular sieve, the content of the doping element with an ionic valence of +3 is 0.01-0.2 wt%, preferably 0.02-0.1 wt%.

6. The method according to any one of claims 1 to 4, wherein: The doping element having an ionic valence state of +4 is selected from at least one of Ti, Zr and Sn, preferably Ti; Preferably, based on the total amount of the MFI molecular sieve, the content of the doping element with an ionic valence of +4 is 0.1-3 wt%, preferably 2-3 wt%.

7. The method according to any one of claims 1 to 6, wherein: In the modified elements, the mass ratio of the rare earth element to phosphorus is 1-10:1, preferably 1-3:1, calculated as the elements; Preferably, in the second catalyst, the content of the rare earth element is 0.01-0.2wt%, preferably 0.05-0.1wt%; the content of the phosphorus element is 0.01-0.1wt%, preferably 0.01-0.04wt%; Preferably, the rare earth element is selected from La and / or Ce.

8. The method according to any one of claims 1 to 7, wherein: The preparation method of the second catalyst comprises: (1) mixing a silicon source, a doping element precursor, an organic template, water and an alcohol to obtain a mixture; wherein the silicon source is an organic silicate, and the molar ratio of the silicon source, the organic template, the alcohol and the water in the mixture calculated as SiO2 is 1:(0.05-0.5):(4-10):(5-100); (2) subjecting the mixture to hydrothermal crystallization, followed by drying and calcining to obtain an MFI molecular sieve; (3) impregnating the MFI molecular sieve with a solution containing a phosphorus source and a rare earth element precursor; (4) contacting the product obtained in step (3) with an alkaline buffer solution of a nitrogen-containing compound.

9. The method according to claim 8, wherein: The mass ratio of the amount of the doping element precursor calculated as the doping element to the silicon source calculated as SiO2 is 0.0001-0.03:1; Preferably, the conditions for the hydrothermal crystallization include: a temperature of 80-200° C. and a time of 0.5-10 days.

10. The method according to any one of claims 1 to 9, wherein: The conditions of the gas phase rearrangement reaction include: a reaction temperature of 300-500°C, preferably 350-400°C, a reaction pressure of 0.1-0.5MPa, preferably 0.1-0.3MPa, a weight space velocity of the reaction raw materials calculated as cyclohexanone oxime of 0.1-16h -1 , preferably 1-8h -1 ; And / or, the conditions of the N-alkylation reaction include: a reaction temperature of 300-500° C., preferably 300-380° C., a reaction pressure of 0.1-0.5 MPa, preferably 0.1-0.3 MPa; Preferably, the temperature of the N-alkylation reaction is 20-100°C lower than the temperature of the gas-phase rearrangement reaction, and further preferably, the temperature of the N-alkylation reaction is 30-50°C lower than the temperature of the gas-phase rearrangement reaction; Preferably, the gas phase rearrangement reaction and N-alkylation reaction are carried out under an inert atmosphere, which is provided by an inert gas.

Citation Information

Patent Citations

  • Preparation method of caprolactam and N-substituted caprolactam

    CN108774172A

  • Catalyst, preparation method thereof and application of catalyst in cyclohexanone-oxime gas-phase Beckmann rearrangement reaction

    CN112138709A

  • Process for preparing caprolactam by cyclohexanone-oxime gas phase rearrangement

    CN1621405A

  • Method for preparing epsilon-caprolactam

    RU2240312C1